S-Biomedics is showing strong performance.
As of 9:27 AM on the 22nd, S-Biomedics is trading at 47,400 KRW on the KOSDAQ market, up 8,400 KRW (21.54%) compared to the previous trading day.
S-Biomedics, a developer of embryonic stem cell therapies, recently announced the development of a new drug that fundamentally treats Parkinson's disease using its platform technology.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
